Japanese Biotech Stock News

Yoshinoya Holdings (TSE:9861) closed out FY 2026 with fourth quarter revenue of ¥59.0b and basic EPS of ¥20.38, alongside trailing twelve month EPS of ¥72.08 and net income of ¥4.7b on revenue of ¥225.7b. Over recent quarters the company’s revenue moved from ¥53.0b in Q4 FY 2025 to ¥59.0b in Q4 FY 2026, with basic EPS progressing from ¥7.29 in Q4 FY 2025 to ¥11.47 in Q1 FY 2026, ¥29.39 in Q2 and ¥10.85 in Q3, before landing at ¥20.38 in the latest quarter. This sets up a narrative in which...

Rorze (TSE:6323) has wrapped up FY 2026 with fourth quarter revenue of ¥34.3b and basic EPS of ¥9.13, alongside trailing twelve month revenue of ¥128.8b and EPS of ¥109.33. Over recent periods the company has seen quarterly revenue move between ¥28.9b and ¥35.2b and basic EPS range from ¥21.88 to ¥38.01, giving investors a clear view of how the top line and EPS have tracked into the latest full year print. With trailing net profit margins softer than the prior year and a large one off loss...

How SoftBank’s Recent Share Performance Frames the Story SoftBank (TSE:9434) has seen its share price slip in recent trading, with a 1 day return of about a 2% decline and negative moves over the past week, month and past 3 months. At the same time, the company reports annual revenue of ¥6.93b and net income of ¥565.67m, with both revenue and net income growth rates in positive territory. This gives investors concrete fundamentals to weigh against recent share performance. See our latest...

Can Do (TSE:2698) closed out FY 2026 with Q4 revenue of ¥22,133 million and a basic EPS loss of ¥16.44, while trailing twelve month EPS stood at ¥27.88 as the company remained profitable over the year despite that quarterly setback. Over recent quarters revenue has moved from ¥20,940 million in Q4 FY 2025 to ¥22,133 million in Q4 FY 2026, with quarterly EPS swinging from a loss of ¥5.69 in Q4 FY 2025 to a profit of ¥22.63 and ¥22.69 in the first half of FY 2026 before sliding back into the...

Fresh from reporting its FY 2026 results, BELLSYSTEM24 Holdings (TSE:6183) posted fourth quarter revenue of ¥36,366 million with basic EPS of ¥27.75, while trailing twelve month EPS came in at ¥110.22 on revenue of ¥145.83 billion as earnings growth over the last year was reported at 2.2%. The company has seen revenue move from ¥143.61 billion to ¥145.83 billion on a trailing basis alongside EPS shifting from ¥108.81 to ¥110.22, giving investors a clearer read on how profit per share is...

Ohba (TSE:9765) has just posted Q3 2026 results with revenue of ¥3,723 million and basic EPS of ¥24.42, giving investors a fresh read on how earnings are tracking against recent quarters. The company has seen quarterly revenue move between ¥3,624 million and ¥6,095 million over the past five reported periods, while basic EPS has ranged from ¥7.81 to ¥30.88. This underscores how earnings can swing even when sales stay within a relatively tight band. With a net profit margin of 8.6% over the...

ABC-MartInc (TSE:2670) has wrapped up FY 2026 with fourth quarter revenue of ¥99,339 million and basic EPS of ¥51.07, setting the tone for how you assess the latest full year showing. The company has seen quarterly revenue range from ¥88,698 million in FY 2025 Q3 to ¥99,339 million in FY 2026 Q4, while basic EPS has moved between ¥37.82 and ¥52.31 over the same stretch. This gives you a clear picture of how the top line and per share earnings have tracked into the current release. With a...

Treasure FactoryLTD (TSE:3093) posts FY 2026 results Treasure FactoryLTD (TSE:3093) has wrapped up FY 2026 with fourth quarter revenue of ¥13.4b and basic EPS of ¥39.42, while trailing 12 month EPS is ¥135.28 on revenue of ¥48.6b and net income of ¥3.2b. Over recent periods the company has reported quarterly revenue increasing from ¥11.7b and basic EPS of ¥32.04 in Q4 FY 2025 to ¥13.4b and ¥39.42 in Q4 FY 2026. This has taken place alongside a 17.1% rise in net earnings over the last 12...

Life (TSE:8194) has wrapped up FY 2026 with fourth quarter revenue of ¥221.9 billion and basic EPS of ¥68.31, rounding out a year where trailing twelve month revenue reached ¥881.3 billion and basic EPS came in at ¥217.55. Over recent periods the company has seen revenue move from ¥850.5 billion and EPS of ¥195.11 in FY 2025’s fourth quarter on a trailing basis to FY 2026’s trailing figures. Over the same period, net income on a trailing basis shifted from ¥18.0 billion to ¥18.8 billion. With...

Furuno Electric FY 2026 earnings snapshot Furuno Electric (TSE:6814) has wrapped up FY 2026 with fourth quarter revenue of ¥37.9 billion and basic EPS of ¥108.36, set against trailing twelve month revenue of ¥140.6 billion and EPS of ¥529.51 that reflect a 46.1% rise in earnings over the past year. Over the past six reported quarters, revenue has moved from ¥33.4 billion in Q4 FY 2025 to ¥37.9 billion in Q4 FY 2026, while basic EPS has ranged from ¥92.38 to ¥210.70. This has fed into a...

Seven & i Holdings (TSE:3382) posts FY 2026 results Seven & i Holdings (TSE:3382) has wrapped up FY 2026 with fourth quarter revenue of ¥2.0 trillion and Basic EPS of ¥40.19, with trailing twelve month EPS at ¥118.81 on revenue of ¥8.9t. Over recent periods the company has seen quarterly revenue range from ¥2.0t to ¥3.2t and Basic EPS move between ¥18.97 and ¥42.14, giving you a clear view of how earnings have translated into that trailing performance. With earnings up 69.2% over the past...

Maxvalu TokaiLtd (TSE:8198) has wrapped up FY 2026 with fourth quarter revenue of ¥98.1b and basic EPS of ¥90.10, anchored by trailing twelve month revenue of ¥385.0b and EPS of ¥321.46 that sit alongside reported earnings growth of 9.2% over the last year. The company has seen quarterly revenue move from ¥97.3b in FY 2025 Q4 to ¥98.1b in FY 2026 Q4, while basic EPS shifted from ¥114.38 to ¥90.10, setting a clear baseline for how the latest print fits into its recent earnings run. With...

Sugi HoldingsLtd (TSE:7649) has just released its FY 2026 numbers, with fourth quarter revenue of ¥260.2 billion and basic EPS of ¥51.47, capping a trailing twelve month period where revenue reached ¥1.0 trillion and basic EPS came in at ¥248.56. Over recent quarters, revenue has moved from ¥243.4 billion in Q4 FY 2025 to ¥260.2 billion in Q4 FY 2026, while basic EPS shifted from ¥36.60 to ¥51.47. This sets up a story where improving net profit margins and higher trailing earnings are the key...

Aeon (TSE:8267) has just closed FY 2026 with fourth quarter revenue of ¥2.97t and basic EPS of ¥30.22, alongside trailing 12 month revenue of ¥10.72t and EPS of ¥26.87, giving investors a clear read on the latest top and bottom line profile. Over recent periods, the company has seen quarterly revenue move from ¥2.66t in FY 2025 Q4 to ¥2.56t in Q1, ¥2.62t in Q2, ¥2.56t in Q3 and ¥2.97t in Q4 of FY 2026. Basic EPS has ranged from a loss of ¥8.23 in FY 2025 Q3 to a profit of ¥30.22 most...

Warabeya Nichiyo Holdings (TSE:2918) closed out FY 2026 with fourth quarter revenue of ¥56.1b and a basic EPS loss of ¥25.52, alongside trailing twelve month revenue of ¥233.8b and EPS of ¥307.31 that reflects earnings growth of 99.3% over the past year. Over recent periods the company has seen quarterly revenue move from ¥53.2b in FY 2025 Q4 to ¥62.1b in FY 2026 Q2, while quarterly EPS has ranged from a loss of ¥54.96 to a gain of ¥142.60. This performance provides the backdrop for reported...

KOMEDA Holdings (TSE:3543) has wrapped up FY 2026 with fourth quarter revenue of ¥14.8b and basic EPS of ¥38.45, setting the tone for a year where trailing twelve month revenue reached ¥57.2b and EPS came in at ¥141.99. Over recent periods, the company has seen quarterly revenue move from ¥12.4b in FY 2025 Q4 to ¥14.8b in FY 2026 Q4, with basic EPS shifting from ¥30.47 to ¥38.45 alongside trailing twelve month net income of ¥6.5b. This puts the latest report in clear focus for anyone tracking...

Kewpie (TSE:2809) opened Q1 2026 with revenue of ¥124.7b and basic EPS of ¥38.96, setting the tone for how its earnings story is evolving off a trading price of ¥3,899. Over the past few quarters, revenue has moved between ¥120.0b in Q1 2025 and ¥131.8b in Q2 2025, while basic EPS ranged from ¥11.96 in Q4 2024 to ¥91.92 in Q1 2025. This gives you a clearer view of how the top line and per share profits have shifted through the recent cycle. With trailing net margin at 4.5% compared with 5.8%...

Why Chugai Pharmaceutical Stock Is On Investors’ Radar Chugai Pharmaceutical (TSE:4519) has attracted attention after recent share price moves, with a 1 day return of about a 1.5% decline and a roughly 1.6% decline over the past week prompting closer scrutiny. These shorter term returns sit against a 1 month return of about an 8.7% decline and a past 3 months gain of roughly 2.6%, which provides a mixed but measurable recent performance profile to assess. See our latest analysis for Chugai...

If you are wondering whether SoftBank Group's current share price reflects its true worth, this breakdown will help you frame what the market might be pricing in right now. The stock closed at ¥3,778, with returns of 4.7% over 7 days, a 2.8% decline over 30 days, an 18.1% decline year to date, and a 125.8% gain over 1 year. The 3 year and 5 year returns sit at 199.2% and 54.4% respectively. Recent headlines around SoftBank Group have focused on its shifting investment profile and ongoing...

Electric Power Development (TSE:9513) cut its earnings guidance for the year ending March 31, 2026, after flagging lower electricity sales, special losses, and smaller expected dividends from its U.S. subsidiary. See our latest analysis for Electric Power Development. The revised guidance lands after a strong run in the shares, with the latest price at ¥4,223 and a 30 day share price return of 10.49% and 90 day share price return of 30.14%. Over a longer horizon, total shareholder return of...

Market reaction to ceasefire news The US-Iran ceasefire announcement triggered a broad rally in Japanese technology stocks, and Resonac Holdings (TSE:4004) moved sharply higher as investors reassessed risks around international trade, technology exports, and energy costs. See our latest analysis for Resonac Holdings. That ceasefire sparked a sharp shift in sentiment toward Resonac, with the stock now at ¥13,030 after a 23.45% 7 day share price return and a very large 1 year total shareholder...

If you have ever wondered whether Aisin's current share price reflects its true worth, this is a good moment to step back and look at what the numbers actually say about value. Aisin's stock is at ¥2,273.5, with a 1.7% return over the last 7 days, a 6.7% decline over 30 days, a 24.3% decline year to date, and returns of 54.9% over 1 year, 103.1% over 3 years, and 102.2% over 5 years. This naturally raises questions about how much risk and potential is already priced in. Recent coverage has...

If you are wondering whether Canon's current share price still reflects good value, focusing on what the market is actually paying for its cash flows, assets and earnings can give you a clearer picture. Canon recently closed at ¥4,425, with returns of 4.0% over 1 year and very strong gains over 3 and 5 years. However, the share price has eased back, with a 0.6% fall over 7 days, 1.1% over 30 days and 6.4% year to date. Recent attention on Canon has been shaped by ongoing interest in its...

Astellas Pharma (TSE:4503) licensed a novel AAV capsid from Dyno Therapeutics, designed for targeted gene therapy delivery to skeletal muscle. This is the first capsid licensed under the Astellas and Dyno collaboration and Dyno's first licensed muscle targeting capsid. The agreement focuses on improving gene therapy delivery and manufacturing efficiency for Astellas's programs. Astellas Pharma, a global pharmaceutical company listed on TSE:4503, has been building out its gene therapy...